Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neuralgia × Gabapentin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 6 Hot Flashes 4 Pain, Postoperative 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Pain 2 Mucositis 2 Vomiting 1 Urinary Bladder Neoplasms 1 Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Psychotic Disorders 1 Oropharyngeal Neoplasms 1 Neurotoxicity Syndromes 1 Neuralgia 1 Neoplasms 1 Nausea 1 Myalgia 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Laryngeal Diseases 1 Ileus 1 Glioblastoma 1 Epilepsy 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Depression 1 Constipation 1 Colonic Neoplasms 1

Interventions

Pregabalin 4 Lidocaine 4 Bupivacaine 3 ziconotide 2 Transcranial Magnetic Stimulation 2 onabotulinum toxin A 1 Yoga 1 Vitamin B 6 1 Vitamin B 12 1 Vinorelbine 1 Vincristine 1 Thalidomide 1 Telmisartan 1 Surveys and Questionnaires 1 Sodium Chloride 1 Saline Solution 1 Paclitaxel 1 Oxycodone 1 Oxaliplatin 1 Low-Level Light Therapy 1 Lidoderm 1 Ketamine 1 KRN 5500 1 Hospitals 1 Geritol 1 Gabapentin 1 Folfox protocol 1 Exercise Therapy 1 Exercise 1 Electroacupuncture 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03747562 2024-09-19

stREnGTH

University Hospital, Ghent

Phase 3 Withdrawn

Head and Neck Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡